cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results

Rhea-AI Summary

cbdMD, Inc. (NYSE American: YCBD), a leading CBD company, has announced a conference call scheduled for August 14, 2024, at 4:20 p.m. Eastern Time. The call will discuss the company's third quarter fiscal 2024 financial results and business progress for the period ending June 30, 2024. Investors and interested parties can join the call using the following details:

- USA/Canada: 844-763-8274
- International: 647-484-8814
- Replay available: USA/Canada (877-344-7529), International (412-317-0088), Passcode: 5067217

A webcast replay will be accessible until August 14, 2025, via the provided link.

Positive

• Proactive investor communication through scheduled earnings call
• Providing multiple access options for investors (phone and webcast)

Negative

• None.

News Market Reaction

-5.12%

1 alert

-5.12% News Effect

On the day this news was published, YCBD declined 5.12%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Charlotte, North Carolina--(Newsfile Corp. - August 5, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, August 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress.

CONFERENCE CALL DETAILS

Wednesday August 14, 2024, 4:20 p.m. Eastern Time
USA/Canada:	844-763-8274
International:	647-484-8814
Teleconference Replay dial in:
USA/Canada:	877-344-7529
International:	412-317-0088
Replay Passcode:	5067217
Webcast/Webcast Replay link - available through August 14, 2025:

https://www.gowebcasting.com/13431

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free¹ CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.

¹ THC-free is defined as below the level of detection using validated scientific analytical tools.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064 email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218832

FAQ

When is cbdMD (YCBD) hosting its Q3 fiscal 2024 earnings call?

cbdMD (YCBD) is hosting its Q3 fiscal 2024 earnings call on Wednesday, August 14, 2024, at 4:20 p.m. Eastern Time.

What period will cbdMD's (YCBD) Q3 fiscal 2024 financial results cover?

cbdMD's (YCBD) Q3 fiscal 2024 financial results will cover the period ending June 30, 2024.

How can investors access cbdMD's (YCBD) Q3 fiscal 2024 earnings call?

Investors can access cbdMD's (YCBD) Q3 fiscal 2024 earnings call via phone (USA/Canada: 844-763-8274, International: 647-484-8814) or through a webcast link provided by the company.

Until when will the webcast replay of cbdMD's (YCBD) Q3 fiscal 2024 earnings call be available?

The webcast replay of cbdMD's (YCBD) Q3 fiscal 2024 earnings call will be available until August 14, 2025.